• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Neural network measures MS disease progression

Article

The percentage of brain volume is an important marker of disease progression in multiple sclerosis. Researchers have developed a prototype neural network-based quantification system to measure this important benchmark by computer-assisted segmentation of multispectral MR imaging data.

The percentage of brain volume is an important marker of disease progression in multiple sclerosis. Researchers have developed a prototype neural network-based quantification system to measure this important benchmark by computer-assisted segmentation of multispectral MR imaging data.

Dr. Axel Wismueller of Ludwig Maximilians University in Munich performed MR exams in six women with relapsing-remitting MS. The neural network computed the percentage of brain volume by automatic cerebrospinal fluid segmentation. The voxel-specific gray-level intensity spectrum forms a seven-dimensional feature vector, which is classified by the neural network as either belonging to CSF or not. Findings were reported at the 2005 European Congress of Radiology.

The neural network-based computation significantly outperformed the conventional angle-image method. Specifically, the neural network performed better by retrieving only T2-weighted and perfusion/diffusion-weighted signals, thereby avoiding misclassifications in white matter lesions that are difficult to distinguish from CSF.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.